相似文献
1
Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure.新型安特卫普评分在预测亚洲心力衰竭患者房颤消融术后心脏功能改善方面的表现。
J Arrhythm. 2025 Apr 11;41(2):e70062. doi: 10.1002/joa3.70062. eCollection 2025 Apr.
2
Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure.新型安特卫普评分在预测亚洲心力衰竭患者房颤消融术后心脏功能改善方面的表现。
J Arrhythm. 2024 Oct 18;40(6):1359-1369. doi: 10.1002/joa3.13162. eCollection 2024 Dec.
3
Editorial to "Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure".《关于“新型安特卫普评分在预测亚洲心力衰竭患者房颤消融术后心脏功能改善中的表现”的社论》
J Arrhythm. 2024 Oct 21;40(6):1370-1371. doi: 10.1002/joa3.13173. eCollection 2024 Dec.
4
Editorial to "Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure".《关于“新型安特卫普评分在预测亚洲心力衰竭患者房颤消融术后心脏功能改善中的表现”的社论》
J Arrhythm. 2024 Oct 24;40(6):1372-1373. doi: 10.1002/joa3.13178. eCollection 2024 Dec.
5
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation.预测房颤消融后左心室射血分数改善的生物标志物。
Heart Rhythm. 2024 Sep;21(9):1581-1588. doi: 10.1016/j.hrthm.2024.04.044. Epub 2024 Apr 11.
6
Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model.心力衰竭患者心房颤动导管消融后左心室功能的恢复：预测模型。
Eur Heart J. 2023 Sep 14;44(35):3327-3335. doi: 10.1093/eurheartj/ehad428.
7
Catheter ablation for atrial fibrillation in congestive heart failure.充血性心力衰竭患者房颤的导管消融治疗
N Engl J Med. 2004 Dec 2;351(23):2373-83. doi: 10.1056/NEJMoa041018.
8
[Impact of NLR on atrial fibrillation recurrence after radiofrequency ablation in atrial fibrillation patients combined with heart failure].[中性粒细胞与淋巴细胞比值对合并心力衰竭的心房颤动患者射频消融术后房颤复发的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Nov 24;50(11):1074-1079. doi: 10.3760/cma.j.cn112148-20220816-00633.
9
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分（CHADS2与CHA2DS2-VASc）对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
10
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.心房颤动心力衰竭中消融与药物治疗的比较：CABANA 试验结果。
Circulation. 2021 Apr 6;143(14):1377-1390. doi: 10.1161/CIRCULATIONAHA.120.050991. Epub 2021 Feb 8.
本文引用的文献
1
Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure.新型安特卫普评分在预测亚洲心力衰竭患者房颤消融术后心脏功能改善方面的表现。
J Arrhythm. 2024 Oct 18;40(6):1359-1369. doi: 10.1002/joa3.13162. eCollection 2024 Dec.
2
Ablation or drug therapy for initial atrial fibrillation.初始房颤的消融或药物治疗。
Ann Cardiothorac Surg. 2024 Jan 30;13(1):71-76. doi: 10.21037/acs-2023-afm-0159. Epub 2024 Jan 23.
3
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.心房颤动的全球流行病学：日益严重的流行趋势及公共卫生挑战。
Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19.
4
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.房颤负担：超越房颤二元实体概念：美国心脏协会科学声明。
Circulation. 2018 May 15;137(20):e623-e644. doi: 10.1161/CIR.0000000000000568. Epub 2018 Apr 16.
5
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.一项基于人群的房颤长期风险研究：伦弗鲁/佩斯利研究的20年随访
Am J Med. 2002 Oct 1;113(5):359-64. doi: 10.1016/s0002-9343(02)01236-6.
Zotero 插件